Skip to main content

Table 2 The study plan

From: Effects of salvianolate on microcirculatory disturbance in patients with stable coronary heart disease: study protocol for a randomized controlled trial

  Screening Immediate phase (intravenous drip of salvianolate for 30 min) In-hospital follow-up
Day 1 Day 1 Day 7
Inclusion/exclusion criteria X   
Informed consent X   
Randomization X   
Demographic information X   
Medical history X   
Vital signs X X X
Physical examination X   X
Concomitant medications X   X
CBC X   X
Scr, BUN, UA X   X
K, Na, Cl X   X
ALT, AST, BIL X   X
Fasting glucose/lipids X   X
cTnT/cTnI X   X
Electrocardiography X   X
Echocardiography X   X
Medication
 Salvianolate injection   X X
End points
 Seattle angina scale X   X
 Quality of life scale X   X
 Holter electrocardiography X   X
 6-min walk test X   X
 IMR X X  
  1. CBC, complete blood count; Scr, serum creatinine; BUN, blood urea nitrogen; UA, uric acid; K, potassium; Na, sodium; Cl, chloride; ALT, alanine aminotransferase; AST, aspartate aminotransferase; BIL, bilirubin; cTnT/cTnI, cardiac troponin T/I; IMR, index of microcirculatory resistance